header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

DISTAL FEMORAL CORTICAL HYPERTROPHY IN HIP ARTHROPLASTY USING A CEMENTLESS DOUBLE-TAPERED FEMORAL STEM

The International Society for Technology in Arthroplasty (ISTA), 28th Annual Congress. PART 1.



Abstract

Purpose

The purpose of this study was to evaluate and compare the clinical, radiological outcomes of the group of patients with distal femoral cortical hypertrophy (DFCH) and without DFCH after hip arthroplasty using a cementless double tapered femoral stem and to analyze a correlation between patients factors and DFCH.

Materials and Methods

Four hundreds four patients (437 hips) who underwent total hip arthroplasty (n = 293) or hemiarthroplasty (n = 144) using a Accolade TMZF femoral stem between Jun 2006 and March 2012 and were follow up period more than 24 months after surgery were enrolled in this study. They were divided into 2 groups, the one group (n = 27) included patients with DFCH, and the other group (n = 410) included patients without DFCH. The mean follow up period was 54.5 months (range, 24 to 85 months) and 56.2 months (range, 24 to 92 months) for patients with DFCH and without DFCH.

Results

The mean HHS, VAS signiï¬cantly improved from 61.4 and 5.5 preoperatively to 95.9 and 1.0 at the ï¬nal follow-up, respectively (P< .001), in the DFCH group and from 57.8 and 4.5 to 91.6 and 0.6 respectively (P< .001), in the control group. There were no signiï¬cant differences between the 2 groups (P> .05). Incidence of the thigh pain in the DFCH group (18.5%) was significantly higher than the control group (2.2%) (P< .001). The mean canal flare index (CFI) and subsidence was 3.71 (range, 2.61 to 5.78) and 1.5 mm (range, 0.1 to 6.1mm) for the DFCH group, 3.30 (range, 1.31 to 5.61) and 3.4 mm (range, 0.33 to 14.9 mm) for the control group. There were significantly differences between 2 groups (p< .002, < .001). The DFCH was significantly correlated with thigh pain and subsidence (p= .001; OR, 11.194; CI, 3.434 to 36.498 for thigh pain, p= .001; OR, 0.080; CI, 0.032 to 0.198 for subsidence), but not with sex. The incidence of DFCH increased significantly with increasing CFI and decreasing age (P= .043; OR, 1.828; CI, 1.018 to 3.280 for CFI; P= .015; OR, 0.968; CI, 0.944 to 0.994 for age). All the femoral stems showed stable fixation and there was no osteolysis or loosening.

Conclusion

The DFCH occurs in 6.2% after hip arthroplasties using a double tapered femoral stem. The DFCH group showed less incidence of vertical subsidence, more younger and larger CFI. Difficult over tight placement of femoral stem to the distal femur results on DFCH, as well as thigh pain in some cases. However, there was no influence on clinical outcomes and femoral stem instability, bony fixation.


*Email: